Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor
- PMID: 2419413
Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor
Abstract
An intrinsic membrane protein with a m.w. of 65,000 that can bind human C8 has been identified after separation of human erythrocyte membrane proteins by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electrotransfer to nitrocellulose sheets. The protein, tentatively designated as the C8-binding protein (C8bp) could be isolated from papain-treated erythrocyte (E) membranes by phenol-water extraction and isoelectric focusing. In a functional assay, with chicken (ch) E as target cells, C8bp inhibited the lysis of ch E C5b67 intermediates by human C8 and C9, whereas the lysis by rabbit C8 and C9 was not affected. Because the decay accelerating factor (DAF) from human erythrocyte membranes also inhibits the activity of C3/C5 convertases in an homologous system, we tested whether or not a DAF activity was present in C8bp. C8bp, however, did not accelerate the decay of the classic C3 convertases. Thus, it appears that C8bp and DAF are two different factors of E membranes with a similar molecular size inhibiting different sites of the activation cascade of complement while they can function synergistically to minimize the self-inflicted damage by complement.
Similar articles
-
Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9.J Immunol. 1986 Mar 1;136(5):1777-82. J Immunol. 1986. PMID: 2419414
-
Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.J Clin Invest. 1987 Jul;80(1):7-12. doi: 10.1172/JCI113065. J Clin Invest. 1987. PMID: 3597779 Free PMC article.
-
The C8-binding protein of human erythrocytes: interaction with the components of the complement-attack phase.Immunology. 1988 Apr;63(4):585-90. Immunology. 1988. PMID: 3366469 Free PMC article.
-
Erythrocyte membrane protein deficiencies in paroxysmal nocturnal hemoglobinuria.Am J Med. 1989 Sep;87(3N):22N-29N. Am J Med. 1989. PMID: 2484793 Review.
-
Structure and function of decay accelerating factor CD55.J Lab Clin Med. 1994 Apr;123(4):485-91. J Lab Clin Med. 1994. PMID: 7511675 Review.
Cited by
-
Inhibition of antibody-dependent lymphocyte cytotoxicity by homologous restriction factor incorporated into target cell membranes.J Exp Med. 1987 Oct 1;166(4):947-55. doi: 10.1084/jem.166.4.947. J Exp Med. 1987. PMID: 3655659 Free PMC article.
-
Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.J Exp Med. 1991 Jul 1;174(1):35-44. doi: 10.1084/jem.174.1.35. J Exp Med. 1991. PMID: 1711565 Free PMC article.
-
The mystery behind membrane insertion: a review of the complement membrane attack complex.Philos Trans R Soc Lond B Biol Sci. 2017 Aug 5;372(1726):20160221. doi: 10.1098/rstb.2016.0221. Philos Trans R Soc Lond B Biol Sci. 2017. PMID: 28630159 Free PMC article. Review.
-
The complement-inhibiting protein, protectin (CD59 antigen), is present and functionally active on glomerular epithelial cells.Clin Exp Immunol. 1991 Feb;83(2):251-6. doi: 10.1111/j.1365-2249.1991.tb05623.x. Clin Exp Immunol. 1991. PMID: 1704296 Free PMC article.
-
Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: identity to sulfated glycoprotein 2, a constituent of rat testis fluid.Proc Natl Acad Sci U S A. 1989 Sep;86(18):7123-7. doi: 10.1073/pnas.86.18.7123. Proc Natl Acad Sci U S A. 1989. PMID: 2780565 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous